{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:38:48Z","timestamp":1789605528692,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s40618-017-0650-x","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T11:11:52Z","timestamp":1490181112000},"page":"859-866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines"],"prefix":"10.1007","volume":"40","author":[{"given":"S.","family":"Behboudi-Gandevani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bidhendi Yarandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Noroozzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"650_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/09513590.2015.1117069","volume":"32","author":"S Behboudi-Gandevani","year":"2016","unstructured":"Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, Farahmand M, Bahri Khomami M, Noroozzadeh M et al (2016) Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol 32:343\u2013353","journal-title":"Gynecol Endocrinol"},{"key":"650_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-9-39","volume":"9","author":"FR Tehrani","year":"2011","unstructured":"Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F (2011) The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 9:39","journal-title":"Reprod Biol Endocrinol"},{"key":"650_CR3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18:618\u2013637","journal-title":"Hum Reprod Update"},{"key":"650_CR4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40618-016-0446-4","volume":"39","author":"Y \u00c7ak\u0131ro\u011flu","year":"2016","unstructured":"\u00c7ak\u0131ro\u011flu Y, Vural F, Vural B (2016) The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. J Endocrinol Invest 39:899\u2013907","journal-title":"J Endocrinol Invest"},{"key":"650_CR5","first-page":"1","volume":"12","author":"U Durmus","year":"2016","unstructured":"Durmus U, Duran C, Ecirli S.(2016) Visceral adiposity index levels in overweight and\/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. J Endocrinol Invest 12:1\u201311","journal-title":"J Endocrinol Invest"},{"key":"650_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1099800410371824","volume":"12","author":"SW Groth","year":"2010","unstructured":"Groth SW (2010) Adiponectin and polycystic ovary syndrome. Biol Res Nurs 12:62\u201372","journal-title":"Biol Res Nurs"},{"key":"650_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.orcp.2006.12.001","volume":"1","author":"YM Rolland","year":"2007","unstructured":"Rolland YM, Haren MT, Patrick P, Banks WA, Malmstrom TK, Miller DK, Morley JE (2007) Adiponectin levels in obese and non-obese middle-aged African-American women. Obes Res Clin Pract 1:1\u201378","journal-title":"Obes Res Clin Pract"},{"key":"650_CR8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(00)00154-3","volume":"92","author":"RH Unger","year":"2000","unstructured":"Unger RH (2000) Leptin physiology: a second look. Regul Pept 92:87\u201395","journal-title":"Regul Pept"},{"key":"650_CR9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1590\/S0100-879X2004000500015","volume":"37","author":"H Mendonca","year":"2004","unstructured":"Mendonca H, Montenegro Junior R, Foss M, Silva de S\u00e1 M, Ferriani R (2004) Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome. Braz J Med Biol Res 37:729\u2013736","journal-title":"Braz J Med Biol Res"},{"key":"650_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2015.09.015","volume":"450","author":"R Huang","year":"2015","unstructured":"Huang R, Yue J, Sun Y, Zheng J, Tao T, Li S et al (2015) Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume. Clin Chim Acta 450:6\u2013369","journal-title":"Clin Chim Acta"},{"key":"650_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.diabres.2006.07.031","volume":"76","author":"T Dogru","year":"2007","unstructured":"Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H et al (2007) Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 76:24\u201329","journal-title":"Diabetes Res Clin Pract"},{"key":"650_CR12","first-page":"E1253- 61","volume":"290","author":"R-Z Yang","year":"2006","unstructured":"Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC et al (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290:E1253- 61","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"650_CR13","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1016\/j.orcp.2008.11.003","volume":"3","author":"Y Miyamoto","year":"2009","unstructured":"Miyamoto Y, Morisaki H, Kokubo Y, Yamanaka I, Tomoike H, Okayama A, Yoshimasa Y, Morisaki T (2009) Resistin gene variations are associated with the metabolic syndrome in Japanese men. Obes Res Clin Pract 3:I\u2013II","journal-title":"Obes Res Clin Pract"},{"key":"650_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","volume":"40","author":"K Polak","year":"2017","unstructured":"Polak K, Czyzyk A, Simoncinin T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest 2017; 40:1\u20138","journal-title":"J Endocrinol Invest"},{"key":"650_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","volume":"15","author":"KA Toulis","year":"2009","unstructured":"Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC et al (2009) Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 15:297\u2013307","journal-title":"Hum Reprod Update"},{"key":"650_CR16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/oby.2008.555","volume":"17","author":"R Drolet","year":"2009","unstructured":"Drolet R, B\u00e9langer C, Fortier M, Huot C, Mailloux J, L\u00e9gar\u00e9 D et al (2009) Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity 17:424\u2013430","journal-title":"Obesity"},{"key":"650_CR17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1373\/clinchem.2004.043109","volume":"51","author":"N Xita","year":"2005","unstructured":"Xita N, Georgiou I, Chatzikyriakidou A, Vounatsou M, Papassotiriou G-P, Papassotiriou I et al (2005) Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 51:416\u2013423","journal-title":"Clin Chem"},{"key":"650_CR18","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1210\/jcem.86.8.7775","volume":"86","author":"JD Veldhuis","year":"2001","unstructured":"Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M (2001) Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome. J Clin Endocrinol Metab 86:3772\u20133778","journal-title":"J Clin Endocrinol Metab"},{"key":"650_CR19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(02)02995-3","volume":"77","author":"MH Telli","year":"2002","unstructured":"Telli MH, Yildirim M, Noyan V (2002) Serum leptin levels in patients with polycystic ovary syndrome. Fertil Steril 77:932\u2013935","journal-title":"Fertil Steril"},{"key":"650_CR20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/0300060516645421","volume":"44","author":"Y Guvenc","year":"2016","unstructured":"Guvenc Y, Var A, Goker A, Kemal Kuscu N (2016) Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res 44:796\u2013805","journal-title":"J Int Med Res"},{"key":"650_CR21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/09513590.2014.968547","volume":"31","author":"DH Kort","year":"2015","unstructured":"Kort DH, Kostolias A, Sullivan C, Lobo RA (2015) Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 31:152\u2013155","journal-title":"Gynecol Endocrinol"},{"key":"650_CR22","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1210\/jc.2006-0936","volume":"91","author":"BK Tan","year":"2006","unstructured":"Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS (2006) Increased visfatin mRNA and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome (PCOS): parallel increase in plasma visfatin. J Clin Endocrinol Metab 91:5022\u20135028","journal-title":"J Clin Endocrinol Metab"},{"key":"650_CR23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2362.2011.02586.x","volume":"42","author":"TK Lajunen","year":"2012","unstructured":"Lajunen TK, Purhonen AK, Haapea M, Ruokonen A, Puukka K, Hartikainen AL et al (2012) Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome. Eur J Clin Invest 42:321\u2013328","journal-title":"Eur J Clin Invest"},{"key":"650_CR24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2012.04.033","volume":"686","author":"K Kazama","year":"2012","unstructured":"Kazama K, Usui T, Okada M, Hara Y, Yamawaki H (2012) Omentin plays an anti-inflammatory role through inhibition of TNF-\u03b1-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol 686:116\u2013123","journal-title":"Eur J Pharmacol"},{"key":"650_CR25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ando.2015.08.002","volume":"76","author":"H-Y Yang","year":"2015","unstructured":"Yang H-Y, Ma Y, Lu X-H, Liang X-H, Suo Y-J, Huang Z-X, et al. (2015) The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Ann Endocrinol 76:620\u2013627","journal-title":"Ann Endocrinol"},{"key":"650_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.fertnstert.2003.06.021","volume":"81","author":"D Panidis","year":"2004","unstructured":"Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D (2004) Serum resistin leve in women with polycystic ovary syndrome. Fertil Steril 81:361\u2013366","journal-title":"Fertil Steril"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-017-0650-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0650-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-017-0650-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T06:30:07Z","timestamp":1500273007000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-017-0650-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,22]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1007\/s40618-017-0650-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,22]]}}}